Location
United Kingdom, Europe
Check Size
$25K - $5M
Investment Stage
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
Medical Devices
About Investor
Shahzad Malik is a General Partner at Advent Life Sciences in London, deploying $25 K–$5 M capital into Series A and B biotech, pharmaceuticals, medical-device and diagnostics companies. He most recently backed NeoDiagnosis, a next-gen point-of-care diagnostic developer. Before Advent, he was a healthcare investment banker at Jefferies, advising life-sciences clients on M&A and capital-markets transactions.
Previous investments
Relief Cardiovascular
12M |2025
Moximed
61M |2024
40M |2022
50M |2017
MiroBio
97M |2022
33M |2019
Similar Investors
MM
Malek Meslemani
United Kingdom, Europe
$5K - $50K
Seed
,Series A
,MW
Michael Whitfield
United Kingdom, Europe
$5K - $50K
Pre Seed
,Seed
,RC
Ronald Cohen
United Kingdom, Europe
$5K - $50K
Pre Seed
,Seed
,JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,RL
Rosemary Leith
United Kingdom, Europe
$5K - $50K
Seed
,Series A
,RS
Russell Smith
United Kingdom, Europe
$5K - $50K
Seed
,Series A
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP